Takeda Pharmaceutical Minority Interest

Takeda Pharmaceutical (TAK) currently reports a minority interest of $990M as of June 2026. That compares with $920M in the prior-year period — up 7.4% year over year. Use the charts on this page to explore Takeda Pharmaceutical's minority interest history and peer comparisons.

Takeda Pharmaceutical's minority interest increased from $920M to $990M — a 7.4% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Takeda Pharmaceutical reported $990M in minority interest as of June 2026. That compares with $920M in the prior-year period — up 7.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current minority interest of $990M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Takeda Pharmaceutical, and consider following TAK for alerts when major investors trade the stock.

Takeda Pharmaceutical is classified in the Healthcare sector. On minority interest, it currently shows $990M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TAK with unrelated industries.